Clinical Trials Browser

Phase 2 × Brain Diseases × Bevacizumab × Clear all

NCT00906516 2009-05-21

Neuradiab® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme

Phase 2 Unknown

Brain Diseases, Brain Neoplasms, Glioblastoma